Literature DB >> 14764192

Measuring the impact of housing on people with schizophrenia.

Graeme Browne1, Mary Courtney.   

Abstract

Review of the available literature, from various countries, on housing options indicates that, for people with a mental illness, boarding houses are the least desirable type of community accommodation and that living in their own home is the most desirable type of accommodation. The present research project provides a more in-depth examination of people with schizophrenia and the impact of living in their own home compared to living in a boarding house. In this Australian study there were 3231 subjects, 3033 who were living in their own homes and 201 living in boarding house accommodation. The study used two instruments from the Mental Health Classification and Service Cost Project, specifically the Health of the Nation Outcomes Scale, which is a measure of current symptoms, and a shortened version of the Life Skills Profile, which measures global level of functioning. Results indicated that while there were no differences in the level of psychiatric symptoms experienced, people living in boarding houses had less access to social support, meaningful activities and work; they also had a significantly lower level of global functioning. These findings contradict the conventional wisdom that people with schizophrenia resort to living in boarding houses because of their level of disability and highlights an area of potential intervention for community health services.

Entities:  

Mesh:

Year:  2004        PMID: 14764192     DOI: 10.1111/j.1442-2018.2003.00172.x

Source DB:  PubMed          Journal:  Nurs Health Sci        ISSN: 1441-0745            Impact factor:   1.857


  9 in total

1.  Utility of functioning measures in the prediction of independent living status in older adults with serious mental illness.

Authors:  Karen L Fortuna; Matthew C Lohman; Martha L Bruce; Stephen J Bartels
Journal:  Int J Geriatr Psychiatry       Date:  2017-08-04       Impact factor: 3.485

2.  Perceived sources of stress and resilience in men in an African American community.

Authors:  Bowen Chung; Marcia Meldrum; Felica Jones; Anthony Brown; Loretta Jones
Journal:  Prog Community Health Partnersh       Date:  2014

3.  Choosing "the best of the hells": mothers face housing dilemmas for their adult children with mental illness and a history of violence.

Authors:  Darcy A Copeland; Marysue V Heilemann
Journal:  Qual Health Res       Date:  2010-11-01

4.  Support in housing: a comparison between people with psychiatric disabilities and people with intellectual disabilities.

Authors:  Oie Umb-Carlsson; Lennart Jansson
Journal:  Community Ment Health J       Date:  2009-12

5.  Associated and mediating variables related to quality of life among service users with mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita
Journal:  Qual Life Res       Date:  2017-10-11       Impact factor: 4.147

6.  Increased risk of nursing home admission among middle aged and older adults with schizophrenia.

Authors:  Alice O Andrews; Stephen J Bartels; Haiyi Xie; William J Peacock
Journal:  Am J Geriatr Psychiatry       Date:  2009-08       Impact factor: 4.105

7.  Frequency and effects of psychosocial interventions additional to olanzapine treatment in routine care of schizophrenic patients.

Authors:  Michael Linden; Lena Pyrkosch; Hans-Peter Hundemer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

8.  Housing model for persons with serious mental illness moderates the relation between loneliness and quality of life.

Authors:  Adi Weiner; David Roe; Michal Mashiach-Eizenberg; Vered Baloush-Kleinman; Hen Maoz; Philip T Yanos
Journal:  Community Ment Health J       Date:  2009-12-25

9.  Predictors of quality of life in a longitudinal study of users with severe mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jacques Tremblay; Norbert Schmitz; Jean Caron
Journal:  Health Qual Life Outcomes       Date:  2013-06-08       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.